Could elderly prostate cancer patients finally ditch long-term hormone shots?
NCT ID NCT06824818
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether elderly men (70+) with prostate cancer who have been on hormone therapy for over 3 years can safely stop it. Researchers will check if their testosterone stays at castrate levels without ongoing treatment. The goal is to see if stopping is feasible and to understand patient interest and outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ELDERLY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Illinois at Chicago (UIC)
RECRUITINGChicago, Illinois, 60607, United States
-
UChicago Medicine Comprehensive Cancer Center
NOT_YET_RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Could a Pre-Surgery nerve block speed up recovery after hip fracture?
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks